Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4842876

COc1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 5/20 0.45
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TNKS O95271 1/20 0.43
GUSB P08236 1/20 0.43
PARP1 P09874 1/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
TBK1 Q9UHD2 7/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
IKBKE Q14164 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4840939 0.90 CHEK2 (0.47) CHEK2NPC1RAB9ATNKSGUSB
Trifluoroacetic Acid SCHEMBL4837278 0.90 HPSE (0.45) NPC1RAB9AKDM4E
Trifluoroacetic Acid SCHEMBL4835232 0.89 HDAC3 (0.50) CHEK2MMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL5262965 0.89 PIN1 (0.51) PARP1KDM4EALDH1A1
SCHEMBL4841493 0.89 NPC1 (0.50) CHEK2NPC1RAB9ATNKSGUSB
Trifluoroacetic Acid SCHEMBL4840737 0.88 HDAC6 (0.44) CHEK2KDM4E
Trifluoroacetic Acid SCHEMBL4837229 0.86 KDM4E (0.40) TBK1KDM4EALDH1A1IKBKEAURKB
Trifluoroacetic Acid SCHEMBL4842729 0.85 AURKA (0.52) CHEK2NPC1RAB9AGUSBPARP1
Trifluoroacetic Acid SCHEMBL4834909 0.85 HDAC6 (0.47) CHEK2MMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4839525 0.85 HDAC6 (0.49) CHEK2AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 CHEK2 309/4885NPC1 2655/4885RAB9A 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.